Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,014.54 -92.57 (-8.36%)

Streaming Delayed Price Updated: 3:35 PM EST, Feb 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Eli Lilly Just Delivered Fantastic News to Shareholders ↗

Today 14:30 EST

The stock price has climbed in the triple digits over three years.

Via The Motley Fool

Topics Government

Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst ↗

Today 13:44 EST

Cantor says Eli Lilly's 2026 outlook eases GLP-1 pricing worries, raises its price target, and expects strong sales growth driven by incretin drugs and orforglipron prescriptions.

Via Benzinga

Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗

Today 13:43 EST

The medications that will be offered via the platform include Novo Nordisk’s popular weight-loss drug Wegovy, Eli Lilly and Company's Zepbound, Amgen’s cholesterol drug Repatha, and Merck’s diabetes...

Via Stocktwits

Topics Economy Government World Trade

P/E Ratio Insights for Eli Lilly and Co ↗

Today 13:00 EST

Via Benzinga

Thursday's session: top gainers and losers in the S&P500 index ↗

Today 12:35 EST

Via Chartmill

Eli Lilly & Co (NYSE:LLY) Stands Out in Recent CANSLIM Growth Stock Screen ↗

Today 4:51 EST

Via Chartmill

Eli Lilly Stock Notches Best Day In 9 Months: Touts $50 Medicare For Obesity Drugs As ‘Compelling Value Proposition’ After Q4 Beat ↗

February 04, 2026

Via Stocktwits

This Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs. ↗

Today 12:13 EST

Structure Therapeutics has a promising GLP-1 drug that is about to enter phase 3 trials.

Via The Motley Fool

Why Eli Lilly (LLY) Shares Are Getting Obliterated Today

Today 11:56 EST

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 7.4% in the morning session after the company discontinued three clinical pipeline assets, including a gene therapy for dementia...

Via StockStory

Topics Artificial Intelligence

Healthcare Titans Propel Dow to Record Highs as GLP-1 Sales Spark Major Market Rotation

Today 11:44 EST

As the first week of February 2026 unfolds, a dramatic shift in investor sentiment has split the U.S. stock market. While technology and artificial intelligence stocks have faced a sharp pullback, the...

Via MarketMinute

Topics Artificial Intelligence Earnings Intellectual Property

Why Eli Lilly Stock Just Dropped ↗

Today 11:08 EST

Hims & Hers has a GLP-1 weight loss pill -- and it's the cheapest one out there.

Via The Motley Fool

HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? ↗

Today 10:58 EST

The company announced the launch of a compounded copy of the Wegovy weight-loss pill at an introductory price of $49 per month.

Via Stocktwits

Topics Intellectual Property

Eli Lilly Beats Q4 Estimates But Shares Slide: Analyst Expects 'Clear Runway Into Next Decade' ↗

Today 10:55 EST

Eli Lilly beats Q4 estimates, backed by sales of Zepbound and Mounjaro. Analyst maintains outperform rating, raises PT to $1,300.

Via Benzinga

Alphabet Inc. (GOOGL): The AI Powerhouse Reaches a $400 Billion Milestone Amid Antitrust Crossroads

Today 9:51 EST

As of February 5, 2026, Alphabet Inc. (NASDAQ: GOOGL) stands at a historic crossroads. The company recently capped off a blockbuster fiscal year 2025, becoming the first digital advertising giant to...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

Hims Is Already Knocking Off Novo's Wegovy Pill — For Just $49 A Month ↗

Today 9:48 EST

Hims & Hers Health launched a knockoff version of Novo Nordisk's already popular weight-loss pill on Thursday.

Via Investor's Business Daily

The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)

Today 9:36 EST

As of February 5, 2026, Eli Lilly and Company (NYSE: LLY) stands as a paradigm-shifting titan in the global healthcare landscape. Having recently crossed the historic $1 trillion market capitalization...

Via Finterra

Topics Earnings Economy Intellectual Property

The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles ↗

Today 9:34 EST

Via MarketBeat

Expert Outlook: Eli Lilly and Co Through The Eyes Of 15 Analysts ↗

Today 9:00 EST

Via Benzinga

Eli Lilly Shares Boosted BY GLP-1s ↗

Today 6:45 EST

On Wednesday, Eli Lilly reported earnings well above expectations, and its shares initially rose by 10%.

Via Talk Markets

Can Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party? ↗

Today 4:05 EST

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.

Via The Motley Fool

LLY Q4 Deep Dive: Obesity Medicines, Pipeline Progress, and Market Expansion Drive Outperformance

Today 0:38 EST

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 42.6% year on year to $19.29 billion. The company’s full-year...

Via StockStory

Why Eli Lilly Stock Soared Today ↗

February 04, 2026

The healthcare giant gained nearly $100 billion in market value.

Via The Motley Fool

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 04, 2026

Via Chartmill

In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk ↗

February 04, 2026

Novo Nordisk shares slide after weak 2026 guidance, while Eli Lilly rallies on strong earnings, booming weight loss drug sales, and a broader pipeline advantage.

Via Benzinga

Wednesday's session: top gainers and losers in the S&P500 index ↗

February 04, 2026

Via Chartmill

Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings ↗

February 04, 2026

Via Benzinga

Eli Lilly Q4 2025 Earnings Call Transcript ↗

February 04, 2026

Eli Lilly and Company (NYSE:LLY) reported fourth-quarter financial results on Wednesday. The transcript from the earnings call has been provided below.

Via Benzinga

Topics Earnings

Eli Lilly (LLY) Stock Trades Up, Here Is Why

February 04, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 10% in the afternoon session after the company reported fourth-quarter 2025 results that beat Wall Street expectations and issued an...

Via StockStory

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗

February 04, 2026

Eli Lilly is riding the GLP-1 gravy train, while this competitor is struggling to get on board.

Via The Motley Fool

Eli Lilly (LLY) Q4 2025 Earnings Call Transcript ↗

February 04, 2026

Eli Lilly (LLY) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Delivering useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/pages/Cabling-Installation-and-Maintenance/298118662118

https://www.instagram.com/cim_magazine/

https://www.linkedin.com/company/3962332

http://twitter.com/CABLINGMAG

Affiliated Brands

DATA CENTER FRONTIER

ISE

LIGHTWAVE

DIGITAL INFRASTRUCTURE GROUP

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions